AtriCure prices $24M stock offering | Wall Street Beat

Wed, 01/16/2013 - 2:24pm
Mass Device

AtriCure says it plans to offer nearly 3.5 million shares at $7.25 apiece, hoping to drum up some $24 million for its atrial fibrillation device. Wall Street Beat

AtriCure (NSDQ:ATRC) priced a public offering of nearly 3.5 million shares of stock at $7.25 per share, saying it expects net proceeds of about $23.5 million.

The West Chester, Ohio-based medical device company said it granted underwriter Piper Jaffray a 30-day over-allotment option for another 521,000 shares.

"AtriCure plans to use the net proceeds from the offering for general corporate purposes and working capital," according to a press release.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.